CUEDC2 and breast cancer: For example, the ubiquitin-binding protein CUEDC2 promotes ERα degradation via the proteasome pathway; consequently, malignant mammary tumors with high CUEDC2 expression under tamoxifen-resistant conditions exhibit low ERα levels (187).